- Case-Based Roundtable
- General Dermatology
- Eczema
- Chronic Hand Eczema
- Chronic Spontaneous Urticaria
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
- Prurigo Nodularis
- Buy-and-Bill
Article
PuriCore partners with Onset Dermatologics
PuriCore, a water-based clean technology company, has entered into a marketing partnership with Onset Dermatologics.
PuriCore, a water-based clean technology company, has entered into a marketing partnership with Onset Dermatologics.
With the arrangement, PuriCore will develop and manufacture a topical hydrogel product for itch symptoms stemming from atopic dermatitis. The product will incorporate PuriCore’s patented Vashe wound therapy technology, and Onset will market and distribute the formulation as Aurstat Anti-Itch Hydrogel, part of the Aurstat Kit. The product is expected to launch in April, according to a news release.
PuriCore recently received 510(k) clearance from the Food and Drug Administration for the Vashe Skin and Wound Hydrogel.
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
